Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

62.29 +1.08 (+1.76%)
Streaming Delayed Price Updated: 9:50 AM EDT, May 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 Next >
Hims & Hers Health, Inc. Prices Upsized $870.0 Million Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare
From Hims & Hers
Via Business Wire
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare
From Hims & Hers
Via Business Wire
Hims & Hers Appoints AI Expert and Former President and CTO at Cruise as Chief Technology Officer
From Hims & Hers
Via Business Wire
Hims & Hers Health, Inc. Reports First Quarter 2025 Financial Results
From Hims & Hers
Via Business Wire
Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer
From Hims & Hers
Via Business Wire
Hims & Hers and Novo Nordisk Team Up to Expand Affordable Access to Care
From Hims & Hers
Via Business Wire
Hims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025
From Hims & Hers
Via Business Wire
Defiance Launches RKLX and HIMZ: 2X Leveraged ETFs for Rocket Lab and Hims & Hers
From Defiance ETFs
Via GlobeNewswire
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
From Hims & Hers
Via Business Wire
Hims & Hers Acquires US-based Peptide Facility
From Hims & Hers
Via Business Wire
Hims & Hers Acquires At-Home Lab Testing Facility, Expanding Capabilities to Ultimately Include Affordable Whole Body Testing for Subscribers
From Hims & Hers
Via Business Wire
Hims & Hers Launches Health Collective and Community Member Council
From Hims & Hers
Via Business Wire
Hims & Hers to Announce Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025
From Hims & Hers
Via Business Wire
The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight
From Hims & Hers
Via Business Wire
Hims & Hers Named to Inc.’s 2024 Best in Business List in Health Products Category
From Hims & Hers
Via Business Wire
Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys
From Hims & Hers
Via Business Wire
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
From Hims & Hers
Via Business Wire
Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue
From Hims & Hers
Via Business Wire
Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results
From Hims & Hers
Via Business Wire
How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals
From Hims & Hers
Via Business Wire
Top 3 Stocks Institutions Are Buying Right Now
Despite the stock market trading at new all-time highs, institutions still find enough reason to buy more enormous stakes in three stocks. 
Via MarketBeat
Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers
From Hims & Hers
Via Business Wire
Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024
From Hims & Hers
Via Business Wire
Top 3 Stocks with Explosive Call Option Activity: What to Watch
Three stocks reported a surge in call option buying recently, showing investors that there could be a path to more upside potential, analysts agree 
Via MarketBeat
Hims & Hers Stock Joins S&P 600: Is More Upside on the Horizon?
There is now a new reason to look into Hims & Hers stock for additional upside, including the new addition to the S&P 600 index alongside double-digit growth. 
Via MarketBeat
Topics Stocks
Exposures US Equities
Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders
From Hims & Hers
Via Business Wire
Invest While You Can: Pullbacks on These 3 Stocks Won’t Last Long
Three stocks stand out for investors to consider as they recently had big selloffs. There are fundamental reasons to believe that these discounts won't last 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Top 3 Stocks to Watch: Options Traders Bet on Big Gains
Three stocks have stood out for call option traders to bet on in the coming months as a view for a recovery rally after an S&P 500 sell-off last week 
Via MarketBeat
Topics Stocks
Exposures US Equities
MarketBeat Week in Review – 8/5 - 8/9
Stocks were looking for direction to end the week, but next week may bring more volatility with the latest reading on inflation and the start of retail earnings 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Hims & Hers Reports Stellar Quarter: Stock Set for a Rally
Hims & Hers stock is showing the market why its fair value is double-digits above where it trades today, with Wall Street analysts to agree 
Via MarketBeat
Topics Bonds ETFs
Exposures Debt Markets
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.